A randomized open label Phase III trial of afatinib versus erlotinib in patients with advanced squamous cell carcinoma of the lung as second line therapy following first line platinum based chemotherapy BI 1200 125 LUX Lung
Supported projects > Other Supported Projects · 2012
Authors: Tuncay GÖKSEL
2012-2013, Other Supported Projects, R & D Project, Completed